IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

Background. Pegylated interferon, ribavirin, and telaprevir triple therapy is a new strategy expected to eradicate the hepatitis C virus (HCV) even in patients infected with difficult-to-treat genotype 1 strains, although adverse effects, such as anemia and rash, are frequent. Methods. We assessed e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chayama, Kazuaki, Hayes, C. Nelson, Abe, Hiromi, Miki, Daiki, Ochi, Hidenori, Karino, Yoshiyasu, Toyota, Joji, Nakamura, Yusuke, Kamatani, Naoyuki, Sezaki, Hitomi, Kobayashi, Mariko, Akuta, Norio, Suzuki, Fumitaka, Kumada, Hiromitsu
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2011
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3307155/
https://ncbi.nlm.nih.gov/pubmed/21628662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jir210
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados